Top 5 Companies in the Breast Cancer Market: Emerging Trends and Key Market Insights
RELEASE DATE: Nov 2024 Author: Spherical Insights Request Free Sample
What Is Breast Cancer?
Human Epidermal Growth Factor Receptor 2 (HER2) is one of the genes that contribute to the development of breast cancer. This protein encourages the body to develop cancer by extending cell proliferation. Compared to patients with other forms of breast cancer, those with positive HER2 receptors exhibit the highest levels of aggressiveness. To cure and destroy the tumor and raise the target on HER2, a variety of treatments are available. Additionally, with more patients each year and a higher incidence of breast cancer recovery, this expands the market for breast cancer.
Key Market Insights:
The global breast cancer market size was valued at USD 31.9 billion in 2022 and is anticipated to be USD 85.5 billion by 2032, exhibiting a CAGR of 10.3% during the forecast period 2022-2032. The top companies in the global breast cancer market include F. Hoffmann-La Roche Ltd., Novartis AG, AstraZeneca PLC, Eli Lilly and Company Inc., Biocon Limited, Merck & Co. Inc., Genentech Inc., Johnson & Johnson, Pfizer Inc., and Bristol-Myers Squibb Company.
Emerging Trends in the Breast Cancer Industry
1. Rising global rate of breast cancer incidence
The market for breast cancer therapy is expected to develop as a result of the rising incidence of breast cancer worldwide. Breast cancer is the second most frequent type of cancer in women and one of the most common malignancies globally. Because the immune system deteriorates with age, cancer risk is frequently linked to aging. Breast cancer diagnoses are more common in women 60 years of age and older, with only a small fraction happening in women under 45, according to the Cancer Treatment Centers of America. According to the American Cancer Society, there will be about 42,690 breast cancer-related fatalities and 279,100 new instances of the disease in the United States in 2020. Furthermore, more than 3.5 million women in the United States were living with breast cancer as of January 2020, according to Breastcancer.org.
2. Growing improved technological advancement and research
Globally, an estimated 2.3 million new cases of breast cancer are identified annually, making it a serious public health issue. In the market for breast cancer, research and development (R&D) is concentrated on enhancing breast cancer detection, diagnosis, and therapy. R&D efforts are concentrated on enhancing screening and detecting techniques. Nowadays, mammography is the most widely used screening method; nonetheless, it has drawbacks, especially for women with dense breast tissue. More sensitive and accurate screening techniques, like 3D mammography and breast MRI, are being researched. Additionally, scientists are investigating the use of proteins and genetic markers as biomarkers for breast cancer detection. Research and development efforts are also being made to increase the precision of breast cancer diagnosis. Although breast cancer is now diagnosed by mammography and biopsy, both methods might be more accurate and require fewer intrusive procedures. Researchers are investigating the use of liquid biopsies that can identify cancer cells in the blood as well as imaging methods like contrast-enhanced mammography and ultrasound.
3. Developments in customized healthcare
Treatment options for breast cancer heavily rely on biomarkers like human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER), and progesterone receptor (PR). Genetic testing, on the other hand, uses DNA analysis to find gene mutations or alterations that could raise the risk of breast cancer or affect treatment choices. For example, screening for BRCA1 and BRCA2 gene variants can assist in determining who is more likely to develop breast cancer and help inform treatment choices, such as prescribing PARP inhibitors to patients who have BRCA mutations. Precision medicine, sometimes referred to as customized medicine, is the process by which medical professionals tailor treatment regimens for specific patients by using genetic tests and biomarkers.
4. Increasing focus on preventive treatments and early recognition
As awareness of the prevalence of breast cancer increases, there may be a greater emphasis on early identification and preventative measures, particularly among populations at higher risk. The creation of therapeutic techniques aimed at stopping the spread of breast cancer in individuals with genetic predispositions including BRCA mutations has gained traction. The focus of breast cancer treatments is shifting from the most effective therapy to proactive disease control and prevention due to this market trend. This is expected to lower the incidence of illness and improve survival rates over the long run.
5. Developments in targeted treatment
The development of tailored therapy regimens that include HER2 inhibitors, CDK4/6 inhibitors, and PARP inhibitors is one of the key factors propelling the market for therapies for the majority of breast cancers. According to this precision-driven approach, individualized treatment plans based on a patient's genetic profile not only improve outcomes for impacted individuals but also lessen adverse effects. Oncologists are finding successful treatments based on the distinct genetic and molecular profiles of each patient due to advancements in genomic profiling and biomarker discovery, which is driving market expansion and investment.
List of Key Companies in the Breast Cancer Industry
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- AstraZeneca PLC
- Eli Lilly and Company Inc.
- Biocon Limited
- Merck & Co. Inc.
- Genentech Inc.
- Johnson & Johnson
- Pfizer Inc
- Bristol-Myers Squibb Company
Top 5 Players in the Breast Cancer Industry
1. F. Hoffmann-La Roche AG
Headquarters: Basel, Switzerland
The Swiss multinational holding healthcare corporation F. Hoffmann-La Roche AG, usually referred to as Roche, has two business divisions: Pharmaceuticals and Diagnostics. Shares of Roche Holding AG, its parent firm, are traded on the SIX Swiss Exchange. Basel is where the organization's headquarter are situated. Roche is the world's top supplier of therapies for cancer and the fifth-largest pharma firm in terms of revenue. F. Hoffmann-La Roche Ltd. is a world leader in the study and management of breast cancer. The company's main goals are to find new targets, improve immunotherapy techniques, and look into novel therapeutic combinations. For almost 30 years, Roche has been a leader in breast cancer research, helping to achieve ground-breaking results in both HER2-positive and triple-negative breast cancers. The goal of their cutting-edge treatments and ongoing clinical trials is to enhance the prognosis of breast cancer patients everywhere.
2. AstraZeneca
Headquarters: Cambridge, United Kingdom.
AstraZeneca PLC is a multinational pharmaceutical corporation that has spent many years at the forefront of breast cancer research and therapy. The Cambridge Biomedical Campus in Cambridge, England, is home to the headquarters of the international pharmaceutical and biotechnology corporation AstraZeneca plc, which is British-Swedish. Its product line addresses key illnesses in the fields of brain, respiratory, gastrointestinal, cardiovascular, cancer, inflammation, and infection. The company's best-selling products include the cholesterol-lowering Crestor, the heart medication Brilinta, the acid reflux treatment Nexium, and the asthma medication Symbicort. AstraZeneca also sells medications to treat diabetes, high cholesterol, pain, and a number of malignancies. Additionally, they concentrate on creating novel medications and working with the outside world to remove obstacles to the best care and improve outcomes for all individuals with breast cancer, irrespective of their location, illness stage, or subtype.
3. Novartis
Headquarters: Basel, Switzerland
The international pharmaceutical company Novartis AG is headquartered in Basel, Switzerland. Novartis, one of the biggest pharmaceutical firms in the world, was the fourth largest by sales in 2022 and is regularly placed in the top five worldwide. Additionally, they concentrate on creating novel treatments for a range of breast cancer forms, such as early-stage hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Novartis wants to revolutionize patient care by finding novel mutations and pathways that could contribute to the course of a disease and creating treatments that will help patients live longer and better lives. Their dedication to promoting health equity and furthering breast cancer research is demonstrated by programs like "More Than Just Words," which attempts to address inequities in breast cancer care.
4. Pfizer Inc
Headquarters: New York City, US
One of the biggest research-based pharmaceutical firms in the world, Pfizer Inc. makes medications for a variety of conditions, including metabolism, oncology, inflammation and immunology, and cardiovascular health. The organization strives to promote wellness, prevention, treatments, and cures for the most dreaded diseases of their day in both developed and emerging regions. Pfizer works with local communities, governments, and healthcare providers to promote and increase access to high-quality, reasonably priced healthcare globally. Pfizer is a global company that generates over 45% of its sales from US markets. Additionally, they concentrate on creating novel treatments for breast cancer, notably metastatic breast cancer (MBC). Pfizer is dedicated to enhancing patient outcomes via clinical trials, research, and collaborations with patient advocacy organizations and medical experts. Their goals are to improve the quality of life for people with breast cancer and offer novel treatment alternatives.
5. Johnson & Johnson
Headquarters: New Jersey, US
Johnson & Johnson was established and is based in New Brunswick, USA. Within the industry of "pharmaceuticals, medicinal chemical & botanical products", the company operates. 'Pharmaceuticals' (ISIC: 21) is the larger sector to which this industry belongs. Businesses in the basic pharmaceutical product manufacturing sector produce medically active ingredients needed to build drugs, such as aspirin, basic vitamins, salicylic acids, and antibiotics, based on their pharmacological characteristics. Businesses that produce chemically pure carbohydrates and process glands and blood are also included in the industry. Additionally, leading healthcare company Johnson & Johnson has long been at the forefront of breast cancer research and therapy. Through clinical trials, research, and collaborations with medical experts and patient advocacy organizations, Johnson & Johnson is dedicated to enhancing patient outcomes. Their goal is to improve the quality of life for people with breast cancer and offer innovative treatment choices.
Conclusion
Breast cancer is still a major global health concern, but millions of people are finding hope because of research breakthroughs, individualized therapies, and early detection. At the forefront, businesses like Johnson & Johnson, Novartis, Pfizer, AstraZeneca, and Roche are advancing breakthroughs that benefit patients all around the world. The outlook for improved survival rates and a higher standard of living for those impacted appears bright, especially with growing awareness and an emphasis on customized treatments. Treating breast cancer is only one aspect of the battle; another is promoting equity, hope, and a future where all patients have an equal opportunity to flourish. For those fighting this illness, their combined efforts are paving the way for a better future.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us